UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048733
Receipt number R000055524
Scientific Title Effects of crocetin on sleep
Date of disclosure of the study information 2022/08/23
Last modified on 2023/01/06 18:17:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of crocetin on sleep

Acronym

Sleep test

Scientific Title

Effects of crocetin on sleep

Scientific Title:Acronym

Sleep test

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the effect on sleep during crocetin ingestion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Indexes on sleeping

Key secondary outcomes

Questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Consume foods containing crocetin once a day just before bedtime for 1 week.

Interventions/Control_2

Consume a placebo food containing no crocetin once a day just before bedtime for 1 week.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

-Healthy males and females aged 45 to 74 years-old.
-Subjects who are a manager or higher and have some sleep complaints or have no sleep complaints according to the pre-sleep questionnaire.
-Subjects who can make self-judgment and arevoluntarily giving written informed consent.

Key exclusion criteria

-Subjects who have taken, or will take during the study period, drugs (e.g., antiallergic drugs, sleep inducing drugs, sleep aids, etc.) that may affect the study one month prior to the start of intake of the study foods.
-Subjects who regularly consume food for specified health use, functional foods, supplements, or health foods that may affect the study more than 3 times a week, and those who are unable to limit their intake during the study period.
-Subjects who with a history or current history of serious heart, liver, kidney, or gastrointestinal diseases.
-Subjects who suspected chronic or acute serious infectious diseases.
-Subjects who are scheduled to be vaccinated during the study period.
-Subjects who are pregnant or planning to become pregnant or breastfeed during the study period.
-Subjects who have excessive alcohol.
-Subjects who with extremely irregular eating habits.
-Subjects who has a BMI of 30 or higher.
-Subjects who plan to change their lifestyle drastically during the study period.
-Subjects whose sleep may be disturbed by external factors (e.g., roommates or pets).
-Subjects who allergic to food.
-Subjects who are currently participating in a clinical study of another drug or health food and who plan to participate in another clinical study within one month after the completion of the study or after giving consent to participate in the study.
-Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Katsuyuki
Middle name
Last name Ishihara

Organization

Calbee, Inc.

Division name

Research Department Research & Development Division

Zip code

321-3231

Address

23-6, Kiyohara-kogyodanchi, Utsunomiya, Tochigi, 321-3231, Japan

TEL

+81-80-5952-8671

Email

k_ishihara@calbee.co.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Osuka

Organization

Calbee, Inc.

Division name

Functional Research Section Research Department Research & Development Division

Zip code

321-3231

Address

23-6, Kiyohara-kogyodanchi, Utsunomiya, Tochigi, 321-3231, Japan

TEL

+81-70-7795-8386

Homepage URL


Email

y_osuka@calbee.co.jp


Sponsor or person

Institute

Calbee, Inc.

Institute

Department

Personal name



Funding Source

Organization

Calbee, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

+81-3-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 04 Day

Date of IRB

2022 Year 08 Month 19 Day

Anticipated trial start date

2022 Year 09 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 08 Month 23 Day

Last modified on

2023 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055524